{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:08:45Z","timestamp":1776352125061,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Finnish Parkinson Foundation"},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnrooth Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liv och H\u00e4lsa Foundation"},{"DOI":"10.13039\/501100001658","name":"Minerva Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001658","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sigrid Juselius Foundation"},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.neuropharm.2015.11.020","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T16:30:14Z","timestamp":1448555414000},"page":"266-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist is neuroprotective and stimulates PGC-1\u03b1 expression and CREB phosphorylation in human dopaminergic neurons"],"prefix":"10.1016","volume":"102","author":[{"given":"Johanna","family":"M\u00e4kel\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timofey V.","family":"Tselykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyrki P.","family":"Kukkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura T.","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.11.020_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPARgamma signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib3","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1515\/hsz-2013-0215","article-title":"Role of the peroxisome proliferator-activated receptors (PPAR)-alpha, beta\/delta and gamma triad in regulation of reactive oxygen species signaling in brain","volume":"394","author":"Aleshin","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson's disease, insulin resistance and novel agents of neuroprotection","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","article-title":"Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in\u00a0vivo","volume":"54","author":"Bogacka","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tins.2005.06.005","article-title":"The many faces of CREB","volume":"28","author":"Carlezon","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/13543784.2015.963195","article-title":"Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease","volume":"24","author":"Carta","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and neurodegenerative disorders","volume":"46","author":"Chen","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mito.2013.12.003","article-title":"Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway","volume":"14","author":"Chiang","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib12","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1210\/me.2010-0134","article-title":"PPARgamma-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on renin gene expression","volume":"24","author":"Desch","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib13","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1074\/jbc.M112.341248","article-title":"Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip\/Idol and the Canopy2 (Cnpy2)\/Mylip-interacting saposin-like protein (Msap)","volume":"287","author":"Do","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","article-title":"Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation","volume":"8","author":"Feige","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib15","doi-asserted-by":"crossref","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","article-title":"Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Fernandez-Marcos","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0896-6273(00)80866-1","article-title":"CREB couples neurotrophin signals to survival messages","volume":"25","author":"Finkbeiner","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1073\/pnas.1109237109","article-title":"A\u00a0role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction","volume":"109","author":"Fusco","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2012.02.017","article-title":"Intercellular (mis)communication in neurodegenerative disease","volume":"73","author":"Garden","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib19","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle","volume":"100","author":"Handschin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","article-title":"Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis","volume":"4","author":"Henchcliffe","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.physiol.010908.163119","article-title":"Transcriptional control of mitochondrial biogenesis and function","volume":"71","author":"Hock","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib22","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1093\/hmg\/ddu317","article-title":"Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1\u03b1","volume":"23","author":"Hyrskyluoto","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cellsig.2004.05.001","article-title":"What turns CREB on?","volume":"16","author":"Johannessen","year":"2004","journal-title":"Cell Signal."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neulet.2010.11.042","article-title":"Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells","volume":"488","author":"Kairisalo","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib25","doi-asserted-by":"crossref","first-page":"e56117","DOI":"10.1371\/journal.pone.0056117","article-title":"Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells","volume":"8","author":"Koivuniemi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/mcne.2000.0935","article-title":"Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus","volume":"17","author":"Korhonen","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib28","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00018-012-1043-0","article-title":"PGC-1alpha: a master gene that is hard to master","volume":"69","author":"Lindholm","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib29","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","article-title":"Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line","volume":"277","author":"Lotharius","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib30","doi-asserted-by":"crossref","first-page":"e11091","DOI":"10.1371\/journal.pone.0011091","article-title":"Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells","volume":"5","author":"Makela","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-2","article-title":"Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1alpha in human dopaminergic neurons via Sirtuin-1","volume":"3","author":"Makela","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.expneurol.2012.02.017","article-title":"Pharmacological manipulation of peroxisome proliferator-activated receptor gamma (PPARgamma) reveals a role for anti-oxidant protection in a model of Parkinson's disease","volume":"235","author":"Martin","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/embor.2011.151","article-title":"CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability","volume":"12","author":"Noriega","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib36","first-page":"33","article-title":"Role of CREB signaling in aging brain","volume":"151","author":"Paramanik","year":"2013","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuint.2006.02.003","article-title":"Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration","volume":"49","author":"Radad","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tibs.2012.12.004","article-title":"The ways and means that fine tune Sirt1 activity","volume":"38","author":"Revollo","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib42","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/db06-1135","article-title":"Adipose mitochondrial biogenesis is suppressed in db\/db and high-fat diet-fed mice and improved by rosiglitazone","volume":"56","author":"Rong","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib43","doi-asserted-by":"crossref","first-page":"179454","DOI":"10.1155\/2011\/179454","article-title":"Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H\/10T1\/2 adipocytes","volume":"2011","author":"Rong","year":"2011","journal-title":"PPAR Res."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib44","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/emboj.2012.38","article-title":"Mitochondrial quality control: a matter of life and death for neurons","volume":"31","author":"Rugarli","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","article-title":"Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration","volume":"71","author":"Saxena","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tem.2012.06.006","article-title":"Transcriptional integration of mitochondrial biogenesis","volume":"23","author":"Scarpulla","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib47","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.cdd.4402160","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"14","author":"Schapira","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib49","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1999.01836.x","article-title":"CREB phosphorylation promotes nerve cell survival","volume":"73","author":"Walton","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.11.020_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/carcin\/bgt023","article-title":"Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma","volume":"34","author":"Xie","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuropharm.2015.11.020_bib52","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:29:16Z","timestamp":1718216956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":52,"alternative-id":["S0028390815301842"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist is neuroprotective and stimulates PGC-1\u03b1 expression and CREB phosphorylation in human dopaminergic neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}